Bo Li

Citée par

	Toutes	Depuis 2019
Citations	16980	16029
indice h	31	29
indice i10	48	47

4700

2350

1175

3525

2014201520162017201820192020202120222023202443 107 138 222 405 684 1660 3159 4685 4376 1459

Accès public

Tout afficher

50 articles

0 article

disponibles

non disponibles

Sur la base des exigences liées au financement

Coauteurs

Xiaole Shirley LiuCEO, GV20 TherapeuticsAdresse e-mail validée de ds.dfci.harvard.edu
Jun S LiuProfessor of statistics, Harvard UniversityAdresse e-mail validée de stat.harvard.edu
Taiwen LiAssociate Professor, West China Hospital of Stomatology, Sichuan UniversityAdresse e-mail validée de scu.edu.cn
Jingxin FuResearch Scientist, Medical Oncology Department, Dana-Farber Cancer InstituteAdresse e-mail validée de ds.dfci.harvard.edu
Peng JiangStadtman Tenure-Track Investigator, National Cancer Institute, NIHAdresse e-mail validée de nih.gov
Xihao HuGV20 TherapeuticsAdresse e-mail validée de gv20therapeutics.com
Myles BrownEmil Frei III Professor of Medicine, Dana-Farber Cancer Institute and Harvard Medical SchoolAdresse e-mail validée de dfci.harvard.edu
Shengqing (Stan) GuThe University of Texas MD Anderson Cancer CenterAdresse e-mail validée de mdanderson.org
Avinash SahuUniversity of New Mexico Cancer Center & TumorAI.orgAdresse e-mail validée de salud.unm.edu
Jun LiCaltech, Stanford (previously), Michigan (current)Adresse e-mail validée de med.umich.edu
Deng Pan, Ph.D.Assistant Professor, Tsinghua UniversityAdresse e-mail validée de tsinghua.edu.cn
Sabina SignorettiProfessor, Brigham and Women's Hospital, Harvard Medical SchoolAdresse e-mail validée de bwh.harvard.edu
Jean-Christophe PignonPrincipal ScientistAdresse e-mail validée de jouncetx.com
Scott RodigProfessor of Pathology, Brigham & Women's HospitalAdresse e-mail validée de bwh.harvard.edu
Hui ShenVan Andel Research InstituteAdresse e-mail validée de vai.org
Vincent B. YoungUniversity of MichiganAdresse e-mail validée de umich.edu
Casey TheriotNC State UniversityAdresse e-mail validée de ncsu.edu
Chongzhi ZangAssociate Professor, University of VirginiaAdresse e-mail validée de virginia.edu
Cliff MeyerDana-Farber Cancer Institute and Harvard T.H. Chan School of Public HealthAdresse e-mail validée de jimmy.harvard.edu
Ruoxu DouDana-Farber Cancer InstituteAdresse e-mail validée de dfci.harvard.edu

Suivre

Bo Li

Associate Professor, University of Pennsylvania

Adresse e-mail validée de chop.edu - Page d'accueil

Cancer genomics Cancer heterogeneity Computational Cancer immunology


Titre Trier par citations Trier par année Trier par titre	Citée par Citée par	Année
TIMER: a web server for comprehensive analysis of tumor-infiltrating immune cells T Li, J Fan, B Wang, N Traugh, Q Chen, JS Liu, B Li, XS Liu Cancer research 77 (21), e108-e110, 2017	4388	2017
Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response P Jiang, S Gu, D Pan, J Fu, A Sahu, X Hu, Z Li, N Traugh, X Bu, B Li, J Liu, ... Nature medicine 24 (10), 1550-1558, 2018	3078	2018
TIMER2. 0 for analysis of tumor-infiltrating immune cells T Li, J Fu, Z Zeng, D Cohen, J Li, Q Chen, B Li, XS Liu Nucleic acids research 48 (W1), W509-W514, 2020	2994	2020
Comprehensive analyses of tumor immunity: implications for cancer immunotherapy B Li, E Severson, JC Pignon, H Zhao, T Li, J Novak, P Jiang, H Shen, ... Genome biology 17, 1-16, 2016	1895	2016
Antibiotic-induced shifts in the mouse gut microbiome and metabolome increase susceptibility to Clostridium difficile infection CM Theriot, MJ Koenigsknecht, PE Carlson Jr, GE Hatton, AM Nelson, ... Nature communications 5 (1), 3114, 2014	978	2014
Resistance to checkpoint blockade therapy through inactivation of antigen presentation M Sade-Feldman, YJ Jiao, JH Chen, MS Rooney, M Barzily-Rokni, ... Nature communications 8 (1), 1136, 2017	804	2017
Landscape of tumor-infiltrating T cell repertoire of human cancers B Li, T Li, JC Pignon, B Wang, J Wang, SA Shukla, R Dou, Q Chen, ... Nature genetics 48 (7), 725-732, 2016	305	2016
Integrated genomic sequencing reveals mutational landscape of T-cell prolymphocytic leukemia MJ Kiel, T Velusamy, D Rolland, AA Sahasrabuddhe, F Chung, NG Bailey, ... Blood, The Journal of the American Society of Hematology 124 (9), 1460-1472, 2014	253	2014
Defining T cell states associated with response to checkpoint immunotherapy in melanoma M Sade-Feldman, K Yizhak, SL Bjorgaard, JP Ray, CG de Boer, ... Cell 176 (1), 404, 2019	200	2019
DNA sensing in mismatch repair-deficient tumor cells is essential for anti-tumor immunity C Lu, J Guan, S Lu, Q Jin, B Rousseau, T Lu, D Stephens, H Zhang, J Zhu, ... Cancer cell 39 (1), 96-108. e6, 2021	177	2021
VIPER: Visualization Pipeline for RNA-seq, a Snakemake workflow for efficient and complete RNA-seq analysis MI Cornwell, M Vangala, L Taing, Z Herbert, J Köster, B Li, H Sun, T Li, ... BMC bioinformatics 19, 1-14, 2018	168	2018
Landscape of B cell immunity and related immune evasion in human cancers X Hu, J Zhang, J Wang, J Fu, T Li, X Zheng, B Wang, S Gu, P Jiang, J Fan, ... Nature genetics 51 (3), 560-567, 2019	130	2019
Cistrome cancer: a web resource for integrative gene regulation modeling in cancer S Mei, CA Meyer, R Zheng, Q Qin, Q Wu, P Jiang, B Li, X Shi, B Wang, ... Cancer research 77 (21), e19-e22, 2017	120	2017
Lactate increases stemness of CD8+ T cells to augment anti-tumor immunity Q Feng, Z Liu, X Yu, T Huang, J Chen, J Wang, J Wilhelm, S Li, J Song, ... Nature communications 13 (1), 4981, 2022	113	2022
A peripheral immune signature of responsiveness to PD-1 blockade in patients with classical Hodgkin lymphoma FZ Cader, X Hu, WL Goh, K Wienand, J Ouyang, E Mandato, R Redd, ... Nature medicine 26 (9), 1468-1479, 2020	104	2020
Investigation of antigen-specific T-cell receptor clusters in human cancers H Zhang, L Liu, J Zhang, J Chen, J Ye, S Shukla, J Qiao, X Zhan, H Chen, ... Clinical Cancer Research 26 (6), 1359-1371, 2020	95	2020
A general framework for analyzing tumor subclonality using SNP array and DNA sequencing data B Li, JZ Li Genome biology 15, 1-23, 2014	90	2014
A SARS-CoV-2 neutralizing antibody with extensive Spike binding coverage and modified for optimal therapeutic outcomes Y Guo, L Huang, G Zhang, Y Yao, H Zhou, S Shen, B Shen, B Li, X Li, ... Nature Communications 12 (1), 2623, 2021	83	2021
Ultrasensitive detection of TCR hypervariable-region sequences in solid-tissue RNA–seq data B Li, T Li, B Wang, R Dou, J Zhang, JS Liu, XS Liu Nature genetics 49 (4), 482-483, 2017	76	2017
Transcriptome deconvolution of heterogeneous tumor samples with immune infiltration Z Wang, S Cao, JS Morris, J Ahn, R Liu, S Tyekucheva, F Gao, B Li, W Lu, ... IScience 9, 451-460, 2018	72	2018

Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.

Articles 1–20

Nombre de citations par an

Citations en double

Citations fusionnées

Ajouter les coauteursCoauteurs

Suivre

Citée par

Coauteurs